These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19040)

  • 21. Purification and properties of dihydrofolate reductase from an amethopterin-resistant strain of Streptococcus faecium.
    D'Souza L; Warwick PE; Freisheim JH
    Biochemistry; 1972 Apr; 11(8):1528-34. PubMed ID: 5021603
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody to dihydrofolate reductase from a methotrexate-resistant subline of the L1210 lymphoma.
    Perkins JP; Hillman G; Fischer D; Bertino JR
    Mol Pharmacol; 1969 May; 5(3):213-8. PubMed ID: 4389029
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinetic investigation of the reaction mechanism of dihydrofolate reductase from L1210 cells.
    McCullough JL; Nixon PF; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():131-42. PubMed ID: 4399849
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydrofolate reductase from the L1210 R murine lymphoma. Further studies on the binding of substrates and inhibitors to the enzyme.
    Hillcoat BL; Perkins JP; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4777-81. PubMed ID: 4383525
    [No Abstract]   [Full Text] [Related]  

  • 26. Implication of a tryptophyl residue in the active site of dihydrofolate reductase.
    Liu JK; Dunlap RB
    Biochemistry; 1974 Apr; 13(9):1807-14. PubMed ID: 4151741
    [No Abstract]   [Full Text] [Related]  

  • 27. A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.
    Rosowsky A; Wright JE; Shapiro H; Beardsley P; Lazarus H
    J Biol Chem; 1982 Dec; 257(23):14162-7. PubMed ID: 7142200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
    Bruckner H; Rubinoff M; Waxman S
    Eur J Cancer (1965); 1980 Aug; 16(8):1057-63. PubMed ID: 6969180
    [No Abstract]   [Full Text] [Related]  

  • 29. Circular dichroic studies on the interaction of dihydrofolate reductase with substrates, coenzymes, and inhibitors.
    D'Souza L; Freisheim JH
    Biochemistry; 1972 Sep; 11(20):3770-4. PubMed ID: 4403684
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies of amino-acid sequence in dihydrofolate reductase from a human methotrexate-resistant cell line KB/6b. Structural and kinetic comparison with mouse L1210 enzyme.
    Pan YC; Domin BA; Li SS; Cheng YC
    Eur J Biochem; 1983 May; 132(2):351-9. PubMed ID: 6840092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
    Duffy TH; Beckman SB; Sato JK; Nagae H; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 23():3-12. PubMed ID: 4072799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DIRECT ASSAY FOR DIHYDROFOLATE REDUCTASE IN HUMAN LEUKOCYTES.
    MISRA DK
    Blood; 1964 May; 23():572-80. PubMed ID: 14142499
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A; Friedkin M
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification and properties of dihydrofolate reductase from cultured mammalian cells.
    Gauldie J; Marshall L; Hillcoat BL
    Biochem J; 1973 Jun; 133(2):349-56. PubMed ID: 4723779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
    Duffy TH; Sato JK; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifolate resistance and the genetic control of dihydrofolate reductase activity.
    Hutchison DJ
    Ann N Y Acad Sci; 1971 Nov; 186():172-81. PubMed ID: 4399850
    [No Abstract]   [Full Text] [Related]  

  • 40. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.